AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05730660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin group
Description: 2 capsules a day of Quercetin Fitosoma® of 250 mg each
Study NCT05730660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: 2 tablets per day, white film-coated having the same appearance as Quercetin Fitosoma ® tablets.
Study NCT05278403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurological physiotherapy
Description: Application of conventional physical therapy techniques.
Study NCT06642012 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cash only
Description: Households received 1 mobile cash transfer per month for 6 months.
Study NCT06642012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cash + Social Behavior Change Communication
Description: Households received 1 mobile cash transfer per month for 6 months but mothers also received an SBCC package that included interpersonal communication (1:1 consultations for mothers), bi-monthly group sessions on key health and nutrition topics, and cooking demonstrations.
Study NCT06642012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cash + top-up cash
Description: Households received 1 mobile cash transfer per month for 6 months, receiving the base cash amount plus an additional cash top-up amount.
Study NCT06639815 — intervention group
Intervention type: OTHER
Intervention: clinical and radiographic examination
Description: clinical and radiographic examination
Study NCT05772702 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed-loop tACS
Description: Individual alpha tACS
Study NCT03931005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaboration Decision Support Guide
Description: Electronic toolkit intended to help organizational leaders select partners and negotiate partnerships for implementation. This will contain: 1) a brief summary of collaboration approaches associated with implementation, 2) detailed descriptions of collaboration strategies, 3) a decision analysis tool that guides the selection of collaborative strategies given the community context, and 4) sample contract or agreement language that specifies the nature of the partnership and expectations.
Study NCT06161649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: accepting the operation process of automated intelligent education software system
Description: 1. Execute registration and qualification review~2. Automated smart education interaction
Study NCT06396403 — intervention group
Intervention type: OTHER
Intervention: Collection of venous blood samples
Description: collection includes 1 EDTA tube and 1 Sarstedt S-Monovette tube of 5 mL
Study NCT06078514 — intervention group
Intervention type: PROCEDURE
Intervention: Loop electrosurgical excision procedure (LEEP)
Description: The affected area of cervix is excised under local anesthesia using a small thin electrically charged hardwire loop for simultaneous cutting and electrocoagulation.
Study NCT04970576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Description: Dose of 20 mg once a day for three months followed by transthoracic echocardiographic assessment for presence/absence of LV thrombus after 4 weeks and 12 weeks
Study NCT04970576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin
Description: Dose as per the target INR of 2 to 3 with transthoracic echocardiographic assessment for presence/absence of LV thrombus after 4 weeks and 12 weeks
Study NCT06016374 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telerehabilitation
Description: During this study, the patient will be asked to use the TeleRé programme at least 5 times a week for 30 minutes for one month. Through the programme, they will have access to exercises in video format and thus self-rehabilitation as well as serious therapeutic games. The self-education games and videos target the functional and motor recovery of the upper limb. In addition, cognitive functions (attention, memory, etc.) will also be stimulated via the programme. Therapeutic education modules and PROMS assessments will also be available.
Study NCT05018598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration via pressurized metered dose inhaler (pMDI)
Description: CHF5993 pMDI
Study NCT05018598 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Administration via pressurized metered dose inhaler (pMDI)
Description: CHF1535 pMDI or CHF5993 pMDI
Study NCT05635409 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STEM-PD
Description: STEM-PD is a cryopreserved cell product, consisting of ventral midbrain dopaminergic progenitor cells derived from the clinical-grade hESC line RC17. STEM-PD will be administered using a non-CE marked class III neurosurgical medical device, the Rehncrona-Legradi device, bilaterally in one surgical session to the putamen.
Study NCT04002063 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT MobileWork-V plus CBT
Description: a smartphone app to assist with CBT homework skills practice plus CBT
Study NCT04002063 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT MobileWork-V plus CBT
Description: a smartphone app to assist with CBT homework skills practice plus CBT
Study NCT04002063 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT alone
Description: CBT therapy individual
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab Deruxtecan
Description: Dato-DXd will be administered as an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered as an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered as an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed will be administered as an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin will be administered an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle for up to 4 cycles.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin will be administered an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle for up to 4 cycles.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin will be administered an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle for up to 4 cycles.
Study NCT05555732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin will be administered an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle for up to 4 cycles.
Study NCT05756829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High frequency, low touch virtual health care
Description: Virtual visits between certified diabetes educators and patients occurring every 2 +/- 1 weeks for a total of 6 months
Study NCT05945355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pro2 - Low Dose - 40% of participant's MIP
Description: Each participant will be provided a PrO2™ device and trained on its use as well as its accompanying PrO2 Fit™ app. The PrO2™ is a flow-resistive device that provides inspiratory resistance via a fixed 2mm orifice and has Bluetooth connectivity to most IOS/Android devices or Mac/Windows computers. The PrO2™ device and app allows for both 100% adherence monitoring and immediate user biofeedback. Successful IMR repetitions will require that subjects achieve a pressure target that is 40% of their MIP (maximum inspiratory pressure).
Study NCT05945355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pro2 - High Dose - 75% of participant's MIP
Description: Each participant will be provided a PrO2™ device and trained on its use as well as its accompanying PrO2 Fit™ app. The PrO2™ is a flow-resistive device that provides inspiratory resistance via a fixed 2mm orifice and has Bluetooth connectivity to most IOS/Android devices or Mac/Windows computers. The PrO2™ device and app allows for both 100% adherence monitoring and immediate user biofeedback. Successful IMR repetitions will require that subjects achieve a pressure target that is 75% of their MIP (maximum inspiratory pressure).
Study NCT05945355 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pro2 - SHAM - 15% of participant's MIP
Description: Each participant will be provided a PrO2™ device and trained on its use as well as its accompanying PrO2 Fit™ app. The PrO2™ is a flow-resistive device that provides inspiratory resistance via a fixed 2mm orifice and has Bluetooth connectivity to most IOS/Android devices or Mac/Windows computers. The PrO2™ device and app allows for both 100% adherence monitoring and immediate user biofeedback. Successful IMR repetitions will require that participants achieve a pressure target that is 15% of their MIP (maximum inspiratory pressure).
Study NCT06633666 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: 1. Fatigue Principal points: Pishu (BL 20), Ganshu (BL 18), Shenshu (BL 23), Baihui (GV 20), Guanyuan (RN 4), Zusanli (ST 36), Sanyinjiao (SP 6)~2. Anxiety/ depression Principal points: Yintang (EX-HN3), Baihui (GV 20), Taichong (LR 3), Neiguan (PC 6), Danzhong (RN 7)~3. Cognitive impairment/ memory loss Principal points: Baihui (GV 20), Sishencong (EX-HN1), Fengfu (GV 16), Taixi (K 13), Xuanzhong (GB 39), Zusanli (ST 36)~4. Insomnia Principal points: Zhaohai (K 16), Shenmai (BL 62), Shenmen (HT 7), Sanyinjiao (SP 6), Anmian (EX-HN22), Sishencong (EX-HN1)
Study NCT06169579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ND-003 tablets
Description: ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
Study NCT06169579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ND-003 tablets
Description: ND-003 tablets will be administered orally over continuous 28-days cycles.
Study NCT06162312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antenatal perineal massage
Description: Participants at 34-35 weeks of gestation were received training in self-perineal massage and performed a daily 5-minute massage using water-based jelly until delivery to compare with standard obstetric care on postpartum morbidities
Study NCT05263791 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Airmod
Description: Both of the respiratory rate monitor (including experimental and reference device) are installed on the enrolled patients. The practitioners can clearly read the result of both devices.
Study NCT06287853 — intervention group
Intervention type: DEVICE
Intervention: Tapestry Biointegrative Implant
Description: The Tapestry RC Biointegrative Implant System is an arthroscopic delivery and fixation system intended for tendon augmentation with Tapestry Biointegrative Implant during arthroscopic rotator cuff (RC) repair. The system combines the biointegrative collagen-based implant (Tapestry Biointegrative Implant) with bioabsorbable fixation ( Bioabsorbable Anchors). Tapestry Biointegrative Implant is a collagen-based implant composed of type I bovine collagen and poly(D,L-lactide). It is designed to function as a non-constricting, protective layer between the tendon and surrounding tissues.
Study NCT06551961 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: methylcellulose
Description: 2.5 and 5 gm Methylcelllose heated to create a gel
Study NCT06551961 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: inulin
Description: 2.5 and 5 gm inulin powder dissolved in water
Study NCT06551961 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: inulin
Description: 2.5 and 5 gm inulin powder dissolved in water
Study NCT06551961 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: maltodextrin
Description: 2.5 and 5gm maltodextrin dissolved in water
Study NCT04879563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ASCAPE-based follow-up strategy
Description: Follow-up through ASCAPE platform including AI-based predictions for health-related QoL issues and suggestions for personalized interventions depending on the type of QoL issue that needs to be tackled.~The ASCAPE-based follow-up strategy includes follow-up through validated QoL questionnaires, wearables for capturing active monitoring data, and mobile apps for answering the questionnaires and capturing potential health-related issues.
Study NCT06640400 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cardiovascular ultrasound
Description: Participants in the intervention group will be treated with a medical LIPUS device (838C-M-L-I/II, Shenzhen, China) for 10 days in addition to conventional medical treatment. The ultrasound therapy instrument is equipped with a sound head comprising 5 transducer units, operating at an ultrasonic frequency of 0.84MHz with a sound intensity range of 1 W/cm2 -1.25 W/cm2. The therapeutic ultrasound sessions necessitate a controlled environmental temperature. Patients will assume the supine position, exposing the precordial region, with the five-pronged head positioned parallel to the heart\&amp;amp;amp;amp;#39;s long axis, covering the entire precordial region including the right and left coronary arterial trunks and the aortic root. The ultrasound therapy device operates in a pulsed mode, with each treatment session lasting 20 minutes, comprising 2 daily sessions for a total of 20 treatments.
Study NCT05445804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 300 mg Cannabidiol
Description: 300 mg CBD in Medium Chain Triglyceride oil b.i.d.
Study NCT05445804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 600 mg Cannabidiol
Description: 600 mg CBD in Medium Chain Triglyceride oil b.i.d.
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Given by PO
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FLUOROURACIL
Description: Given by IV
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given by PO
Study NCT05445804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Medium Chain Triglyceride oil
Study NCT06539897 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual education
Description: These sessions of the sexual education program aim to increase women's knowledge and awareness about their own bodies. Women are informed about their own bodies, their identities, and the stages of sexual response, aiming to make the process clearer and more understandable. They will be encouraged to discover what sexuality means to them, their knowledge about sexuality will be questioned, and sexual myths, if any, will be revealed, and correct information about sexual myths will be provided to normalize sexuality. In addition, discussions will be held on the meanings of being a woman and an older woman, and women's perspectives on themselves and their self-esteem will be emphasized. In the third session, participants will be taught effective communication techniques to improve their communication skills with their partners.
Study NCT05946239 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manage My Pain App
Description: This digital application helps patients measure, track, and manage chronic pain, functionality, and medication use. MMP can also be used to share patient pain experiences with their circle of care via reports and offers educational resources for patients.
Study NCT05887661 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hypovolemic phlebotomy
Description: hypovolemic phlebotomy was performed after induction of anesthesia and before the star of parenchymal division, with a goal-directed low central venous pressure drop to 5mmHg.
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Given by IV
Study NCT00053339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tamoxifen
Study NCT00053339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Given by IV
Study NCT05062317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given by IV
Study NCT04752657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delayed administration of survey modules
Description: The intervention consists in delaying the administration of the physical function, physical activity, and events survey modules by 2 weeks
Study NCT04752657 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Regular administration of survey modules
Description: The physical function, physical activity, and events survey modules are administered according to the regular pattern
Study NCT05101213 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Virus-specific Cytotoxic T-lymphocytes
Description: Given IV
Study NCT05222906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venglustat
Description: tablet; oral
Study NCT05222906 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: imiglucerase
Description: sterile lyophilized product; intravenous
Study NCT06099717 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual-cantilevered implant bridge
Description: A 3-unit supported by one implant in the middle
Study NCT06099717 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3-unit iFDP
Description: 3-unit fixed dental prosthesis supported by two implants
Study NCT05604612 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Corticision
Description: Incisions in the cortical plate of maxillary bone
Study NCT04904146 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
Description: The study aims to perform systematic translational sampling of each patient from study start until end-of-study, or at longest for a three year period for each patient. Treatment will be performed according to clinical routine.
Study NCT06415578 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ergonomics training
Description: In this training; What is ergonomics, the importance of ergonomics, the purpose of ergonomics, risk factors for musculoskeletal disorders that can be seen in e-sports players, ergonomic arrangements that can be made in the working environment and methods of protection from musculoskeletal injuries, posture disorders and various ergonomic arrangements that can be made for posture disorders and chair selection, screen selection. selection and rest breaks were included. Participants will be trained twice in total, on the first day of the study and at the end of the 4th week. The training will be carried out interactively, supported by videos and visuals. Training will be done individually and will last approximately 2 hours.
Study NCT06415578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ergonomics training
Description: In this training; What is ergonomics, the importance of ergonomics, the purpose of ergonomics, risk factors for musculoskeletal disorders that can be seen in e-sports players, ergonomic arrangements that can be made in the working environment and methods of protection from musculoskeletal injuries, posture disorders and various ergonomic arrangements that can be made for posture disorders and chair selection, screen selection. selection and rest breaks were included. Participants will be trained twice in total, on the first day of the study and at the end of the 4th week. The training will be carried out interactively, supported by videos and visuals. Training will be done individually and will last approximately 2 hours.
Study NCT06415578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: The exercise training program will be implemented for 8 weeks, 3 days a week, lasting an average of 45 minutes. All participants will be given information about the exercises before the exercise training. The exercise protocol was designed as 3 parts: warm-up, exercise and cool-down. Stretching exercises, mobility and strength exercises will be applied. A rest period of 30-45 seconds was given between sets and 2-3 minutes between exercises. Participants will be given dynamic and static stretching, nerve stretching, postural strength and functional exercises for the upper extremity. Relevant movements will be modified according to the exercise capacity of the participants. Exercise content will also include median, ulnar and radial nerve stretching, neck and thoracic mobility exercises, and functional strength exercises for the shoulder, arm, hand and wrist. Exercise tracking will be checked regularly through online conversations.
Study NCT06177834 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alisklamp
Description: Alisklamp
Study NCT06177834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dorsal slit circumcision technique
Description: In this group, included the patients who will operated with dorsal slit circumcision technique
Study NCT05684159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NM8074
Description: NM8074 will be administered as an intravenous infusion. In Cohort 1, all subjects will be administered 20 mg/kg of NM8074 intravenously every two weeks for a total of 7 doses from Day 1 to Day 85 of the Treatment Period. Patients in Cohort 2 will receive weekly doses of 10 mg/kg for a total of 4 doses from Day 1 to Day 22 followed by biweekly doses at 20 mg/kg for a total of 5 doses from Day 29 to Day 85.